Results 181 to 190 of about 3,954,159 (357)

LDB2 is a novel diagnostic and prognostic biomarker and inhibits bladder cancer metastasis by activating p38 MAPK/ERK1/2/JNK signaling pathway [PDF]

Yue Li, Bin Zhao, Wenzhi Gao, Yucai Wu, Tai Tian, Shimeng Zhao, Jilong Zhang, Ran Li, Shiming He, Yanqing Gong, Jianguo Ma, Xuesong Li   +11 more
openalex   +1 more source

Editor's evaluation: NMNAT promotes glioma growth through regulating post-translational modifications of P53 to inhibit apoptosis

, 2021
Patrik Verstreken
openalex   +1 more source

B-Raf/VEGFR-2 Inhibitor RAF265 [PDF]

, 2020
National Cancer Institute
openalex   +1 more source

Hsp90 Inhibitors [PDF]

Journal of Thoracic Oncology, 2012
Pillai, Rathi N., Ramalingam, Suresh S.
openaire   +2 more sources

Dimethyl fumarate combined with cisplatin at subcytotoxic doses sensitizes cervical cancer toward ferroptosis and apoptosis through GSH restriction and p53 (re)activation

Molecular Oncology, EarlyView.
Dimethyl fumarate (DMF) reduces growth of HPV‐positive cervical cancer spheroids and induces ferroptosis in cervical cancer cells via blocking SLC7A11/Glutathione (GSH) axis. Combination of subcytotoxic doses of DMF and cisplatin (CDDP) further suppresses spheroid growth and drives cell death in 2D culture models.
Carolina Punziano, Giuseppina Minopoli, Simona Romano, Laura Marrone, Katia Aquilano, Maria Lina Tornesello, Raffaella Faraonio   +6 more
wiley   +1 more source

Metabolomics profiling of acute myelogenous leukemia patients to identify systemic differences associated with in vitro sensitivity to SYK inhibitors. [PDF]

Metabolomics
Brattås MK, Hatfield KJ, Paulsen Rye K, Reikvam H.   +3 more
europepmc   +1 more source

Synthesis and Evaluation of Imidazole Acetic Acid Inhibitors of Activated Thrombin-Activatable Fibrinolysis Inhibitor as Novel Antithrombotics

, 2003
James C. Barrow, Philippe G. Nantermet, Shaun R. Stauffer, Phung L. Ngo, Melissa A. Steinbeiser, Shi‐Shan Mao, Steven S. Carroll, Carolyn Bailey, Dennis Colussi, Michelle Bosserman, Christine Burlein, Jacquelynn J. Cook, Gary R. Sitko, Philip R. Tiller, Cynthia Miller‐Stein, Mark J. Rose, Daniel R. McMasters, Joseph P. Vacca, Harold G. Selnick   +18 more
openalex   +1 more source

Targeted modulation of IGFL2‐AS1 reveals its translational potential in cervical adenocarcinoma

Molecular Oncology, EarlyView.
Cervical adenocarcinoma patients face worse outcomes than squamous cell carcinoma counterparts despite similar treatment. The identification of IGFL2‐AS1's differential expression provides a molecular basis for distinguishing these histotypes, paving the way for personalized therapies and improved survival in vulnerable populations globally.
Ricardo Cesar Cintra, Lucca Paolo Hsu Helmich, Daniel Rodrigues de Bastos, Laura Sichero, Patrícia Savio de Araujo‐Souza, Fabio Passetti, Luisa Lina Villa   +6 more
wiley   +1 more source

Direct Switch From Iptacopan to Pegcetacoplan in a Patient With Paroxysmal Nocturnal Hemoglobinuria. [PDF]

EJHaem
Latyshev V, Fidarova Z, Lukina E, Parovichnikova E.   +3 more
europepmc   +1 more source

POS-044 INCIDENCE, PREDICTORS, AND CLINICAL OUTCOME OF ACUTE KIDNEY INJURY IN PATIENTS TREATED WITH PD-1 INHIBITORS: A SINGLE CENTER OBSERVATIONAL STUDY

, 2022
Zhongke Qin, K. Liu, Xianrong Xu, Tian Li, Yichen Ge, Buyun Wu, C. Xing, Huijuan Mao   +7 more
openalex   +1 more source